Paper38136208
Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough?
Grujić-Milanović J and 6 others. Antioxidants (Basel), 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough? Papers, record 38136208. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136208
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough?
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References141
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19651200 | Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? | J Ethnopharmacol | 2009 | https://conductscience.org/library/papers/19651200 | PubMed |
| 2 | 37087452 | The global prevalence of myocardial infarction: a systematic review and meta-analysis. | BMC Cardiovasc Disord | 2023 | https://conductscience.org/library/papers/37087452 | PubMed |
| 3 | 27150174 | The Epidemiology of Atrial Fibrillation and Stroke. | Cardiol Clin | 2016 | https://conductscience.org/library/papers/27150174 | PubMed |
| 4 | 33737232 | Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone. | Heart Rhythm | 2021 | https://conductscience.org/library/papers/33737232 | PubMed |
| 5 | 29089889 | Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/29089889 | PubMed |
| 6 | 35572911 | Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis. | J Thorac Dis | 2022 | https://conductscience.org/library/papers/35572911 | PubMed |
| 7 | 19935903 | Inhibitory effects of dauricine on early afterdepolarizations and L-type calcium current. | Can J Physiol Pharmacol | 2009 | https://conductscience.org/library/papers/19935903 | PubMed |
| 8 | 33738923 | Non-pharmacological management of hypertension. | J Clin Hypertens (Greenwich) | 2021 | https://conductscience.org/library/papers/33738923 | PubMed |
| 9 | 25728312 | Red yeast rice for the treatment of dyslipidemia. | Curr Atheroscler Rep | 2015 | https://conductscience.org/library/papers/25728312 | PubMed |
| 10 | 29633164 | Xueshuantong Injection (Lyophilized) Attenuates Cerebral Ischemia/Reperfusion Injury by the Activation of Nrf2-VEGF Pathway. | Neurochem Res | 2018 | https://conductscience.org/library/papers/29633164 | PubMed |
| 11 | 36547903 | Regulation of Inflammation-Mediated Endothelial to Mesenchymal Transition with Echinochrome a for Improving Myocardial Dysfunction. | Mar Drugs | 2022 | https://conductscience.org/library/papers/36547903 | PubMed |
| 12 | 33062142 | Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33062142 | PubMed |
| 13 | 35459727 | Heart valve disease: a journey of discovery. | Heart | 2022 | https://conductscience.org/library/papers/35459727 | PubMed |
| 14 | 33187128 | Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies. | Life (Basel) | 2020 | https://conductscience.org/library/papers/33187128 | PubMed |
| 15 | 25897793 | Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis. | Atherosclerosis | 2015 | https://conductscience.org/library/papers/25897793 | PubMed |
| 16 | 26654920 | Electrolyte disturbances differentially regulate sinoatrial node and pulmonary vein electrical activity: A contribution to hypokalemia- or hyponatremia-induced atrial fibrillation. | Heart Rhythm | 2016 | https://conductscience.org/library/papers/26654920 | PubMed |
| 17 | 26869811 | The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial. | Integr Blood Press Control | 2016 | https://conductscience.org/library/papers/26869811 | PubMed |
| 18 | 36942453 | Peroxisome proliferator-activated receptor δ improves the features of atherosclerotic plaque vulnerability by regulating smooth muscle cell phenotypic switching. | Br J Pharmacol | 2023 | https://conductscience.org/library/papers/36942453 | PubMed |
| 19 | 27995995 | Ascorbic Acid Protects against Hypertension through Downregulation of ACE1 Gene Expression Mediated by Histone Deacetylation in Prenatal Inflammation-Induced Offspring. | Sci Rep | 2016 | https://conductscience.org/library/papers/27995995 | PubMed |
| 20 | 26396675 | Effect of berberine on acetylcholine-induced atrial fibrillation in rabbit. | Am J Transl Res | 2015 | https://conductscience.org/library/papers/26396675 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42074444 | Smoking, Nutritional Status, and Their Associations with Hypertension and Hematological Disorders Among Hotel Workers: Implications for Indonesian Occupational Health Nursing. | Int J Environ Res Public Health | 2026 | https://conductscience.org/library/papers/42074444 | PubMed |
| 41908092 | Research Advances on Targets and Mechanisms in Cancers Complicated by Cardiovascular Diseases. | Onco Targets Ther | 2026 | https://conductscience.org/library/papers/41908092 | PubMed |
| 41511723 | Advances in natural compounds modulating autophagy for the therapeutic intervention of heart failure. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41511723 | PubMed |
| 40603485 | Association between residential proximity to major roadways and nonfatal cardiovascular disease in Chinese older adults: a nationwide study. | Sci Rep | 2025 | https://conductscience.org/library/papers/40603485 | PubMed |
| 39845374 | Nanocurcumin in myocardial infarction therapy: emerging trends and future directions. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39845374 | PubMed |
| 38999868 | Panax notoginseng: Pharmacological Aspects and Toxicological Issues. | Nutrients | 2024 | https://conductscience.org/library/papers/38999868 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136208
GET https://conductscience.org/api/papers/v1/38136208/references?page=2